Product Code: ETC323129 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Philippines drug discovery services market has experienced a CAGR of around 15%. The pharmaceutical industry`s research and development efforts have contributed to this growth.
The Philippines drug discovery services market is experiencing substantial growth due to several key drivers. One of the primary drivers is the increasing demand for novel and effective drugs to combat various diseases prevalent in the country. The rising incidence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has prompted pharmaceutical companies and research institutions to invest significantly in drug discovery services. Additionally, the government`s initiatives to promote research and development in the healthcare sector through funding and policy support are also contributing to the growth of the market.
The drug discovery services market faces challenges such as increasing research complexity and the need for advanced technologies. Adapting to new drug discovery methods and offering innovative solutions is essential in this rapidly evolving field.
The Philippines drug discovery services market has experienced disruptions due to the pandemic. The research and development activities in the pharmaceutical industry have been affected by lockdowns, travel restrictions, and limitations on laboratory operations. This has led to delays in drug discovery projects and a temporary decline in demand for related services.
Key players in the Philippines Drug Discovery Services Market include Chemrez Technologies Inc., Novartis Healthcare Philippines Inc., and GlaxoSmithKline Philippines Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Drug Discovery Services Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Drug Discovery Services Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Drug Discovery Services Market - Industry Life Cycle |
3.4 Philippines Drug Discovery Services Market - Porter's Five Forces |
3.5 Philippines Drug Discovery Services Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.6 Philippines Drug Discovery Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Philippines Drug Discovery Services Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Philippines Drug Discovery Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development activities in the pharmaceutical industry in the Philippines |
4.2.2 Growing prevalence of chronic diseases driving the demand for innovative drug discovery services |
4.2.3 Government initiatives to promote and support the biopharmaceutical sector in the country |
4.3 Market Restraints |
4.3.1 Lack of skilled workforce and expertise in drug discovery services |
4.3.2 Stringent regulations and lengthy approval processes for new drug development in the Philippines |
5 Philippines Drug Discovery Services Market Trends |
6 Philippines Drug Discovery Services Market, By Types |
6.1 Philippines Drug Discovery Services Market, By Process |
6.1.1 Overview and Analysis |
6.1.2 Philippines Drug Discovery Services Market Revenues & Volume, By Process, 2021-2031F |
6.1.3 Philippines Drug Discovery Services Market Revenues & Volume, By Target Selection, 2021-2031F |
6.1.4 Philippines Drug Discovery Services Market Revenues & Volume, By Target Validation, 2021-2031F |
6.1.5 Philippines Drug Discovery Services Market Revenues & Volume, By Hit-to-Lead identification, 2021-2031F |
6.1.6 Philippines Drug Discovery Services Market Revenues & Volume, By Lead Optimization, 2021-2031F |
6.1.7 Philippines Drug Discovery Services Market Revenues & Volume, By Candidate Validation, 2021-2031F |
6.2 Philippines Drug Discovery Services Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Drug Discovery Services Market Revenues & Volume, By Chemistry Services, 2021-2031F |
6.2.3 Philippines Drug Discovery Services Market Revenues & Volume, By Biology Services, 2021-2031F |
6.3 Philippines Drug Discovery Services Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Philippines Drug Discovery Services Market Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021-2031F |
6.3.3 Philippines Drug Discovery Services Market Revenues & Volume, By Academic Institutes, 2021-2031F |
6.3.4 Philippines Drug Discovery Services Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Drug Discovery Services Market Import-Export Trade Statistics |
7.1 Philippines Drug Discovery Services Market Export to Major Countries |
7.2 Philippines Drug Discovery Services Market Imports from Major Countries |
8 Philippines Drug Discovery Services Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and academic institutions in the Philippines |
8.2 Percentage increase in government funding for biopharmaceutical research and development |
8.3 Number of patents filed for new drug discoveries in the Philippines |
8.4 Growth in the number of clinical trials conducted for new drug compounds in the country |
9 Philippines Drug Discovery Services Market - Opportunity Assessment |
9.1 Philippines Drug Discovery Services Market Opportunity Assessment, By Process, 2021 & 2031F |
9.2 Philippines Drug Discovery Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Philippines Drug Discovery Services Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Philippines Drug Discovery Services Market - Competitive Landscape |
10.1 Philippines Drug Discovery Services Market Revenue Share, By Companies, 2024 |
10.2 Philippines Drug Discovery Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |